HIV & AIDS

'Geneva patient' the latest in long-term remission from HIV

A man dubbed the "Geneva patient" is the latest person with HIV to be declared in long-term remission—however he did not receive a transplant with a virus-blocking gene mutation like previous cases, researchers said on ...

Medications

Don't take chances: Why doxycycline is a great bet against STIs

If taken within 72 hours of condomless sex, the common antibiotic doxycycline drastically reduces the risk of gonorrhea, syphilis and chlamydia among transwomen and gay, bisexual and other men who have sex with men, a recent ...

HIV & AIDS

'End of AIDS' still possible by 2030: UN

"The end of AIDS" is still possible by 2030, the United Nations insisted Thursday, but cautioned that the world's deadliest pandemic could only be halted if leaders grasped the opportunity.

Medical research

A potential new target to treat HIV infection

Researchers at Johns Hopkins Medicine, in collaboration with researchers at the National Institutes of Health, report that two new studies in mice with a humanized immune system and human cell lines have identified an enzyme ...

HIV & AIDS

International migrants left behind in HIV response: Study

International migrants in Australia and beyond are at increased risk of HIV infection due to reduced access to a highly effective prevention measure, a world-first global review led by Monash University has found.

Medical research

PrEP implant that protects against HIV could be near

Animal research is pointing toward a new way to prevent HIV infection: a refillable implant that continuously delivers antiretroviral medications for up to 20 months at a time.

page 14 from 40